|
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome
|
Nov 2017
|
Biology of Blood and Marrow Transplantation
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia
|
May 2020
|
Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation
|
aplastic anemia
|
|
Why Hurry Up and Wait? Transplantation in Lower-Risk Myelodysplastic Syndromes
|
Sep 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
myelodysplastic syndromes (MDS)
|
|
A Case Series of Post-Transplantation Cyclophosphamide in Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia
|
Jun 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
aplastic anemia
|
|
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MAC comp
|
Sep 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
|
Dec 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
aplastic anemia
|
|
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
|
Aug 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
myelodysplastic syndromes (MDS)
|
|
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis
|
Jun 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
myelodysplastic syndromes (MDS)
|
|
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
|
Nov 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
myelodysplastic syndromes (MDS)
|
|
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia
|
May 2019
|
Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation
|
aplastic anemia
|
